Clinical Trials Directory

Trials / Unknown

UnknownNCT01287286

Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy

Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy- a Double Blinded, Randomized, Placebo-controlled Trial

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate if food supplements,Antrodia cinnamomea, could minimize the gastrointestinal symptom of cancer patients with chemotherapy.

Detailed description

In our unpublished report shows that patients who took Antrodia Cinnamomea compound of 15 milliliters liquid twice in a day, might help white blood cells, red blood cells and hemoglobin increase after 2 months; liver glutamic pyruvic transaminase(GPT) index mitigation, P \<0.05 difference statistically; In addition, liver glutamate oxaloacetate transaminase(GOT) and biochemical index of renal function had no abnormal data statistically. However, cancer patients with gastrointestinal disorders after chemotherapy is known to be a common side effect, we seek to investigate if Antrodia Cinnamomea improves the function of gastrointestinal system.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAC-CanAntrodia cinnamomea compounds of 15 milliliters liquid per pack, oral post meal, twice in a day for 30 days
DIETARY_SUPPLEMENTplaceboPlacebo of 15 milliliters liquid per pack, oral post meal, twice in a day for 30 days

Timeline

Start date
2010-06-01
Primary completion
2011-04-01
Completion
2012-05-01
First posted
2011-02-01
Last updated
2011-02-08

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01287286. Inclusion in this directory is not an endorsement.